Since our founding in 2010, we have worked to build the industry's leading mRNA technology platform, the infrastructure to accelerate drug discovery and early development, a rapidly expanding pipeline, and a world-class team. Our pipeline includes development candidates for mRNA-based vaccines and therapies spanning several therapeutic areas, and we have multiple clinical trials underway with other development candidates progressing toward the clinic. In addition, we have numerous discovery programs advancing toward development.

---

Other topics

1. 
   Presidents day
2. Technical Analysis
3. 
   Amazon Pharmacy
4. LMND
5. Semiconductor
6. 
   Facebook
7. Minimalism
8. Thailand
9. Roblox
10. Blue Chips stock
11. 
    Capitulation
12. 
    Pepsi
13. Earnings
14. 
    Compounding
15. 
    Jeff Bezos